Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
US Army

Generated: June 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020772

« Back to Dashboard

NDA 020772 describes SUCRAID, which is a drug marketed by Qol Medcl and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the SUCRAID profile page.

The generic ingredient in SUCRAID is sacrosidase. One supplier is listed for this compound. Additional details are available on the sacrosidase profile page.
Summary for 020772
Applicant:Qol Medcl
Therapeutic Class:Enzyme Replacements/Modifiers
Pharmacology for NDA: 020772
Suppliers and Packaging for NDA: 020772
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SUCRAID sacrosidase SOLUTION;ORAL 020772 NDA QOL Medical, LLC 67871-111 N 67871-111-04

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;ORALStrength8,500 IU/ML
Approval Date:Apr 9, 1998TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Feb 7, 2034Product Flag?YSubstance Flag?YDelist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Daiichi Sankyo
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.